AAAAAA
Results:
1-14
|
Results: 14
Authors:
Newton, DL
Hansen, HJ
Liu, HT
Ruby, D
Iordanov, MS
Magun, BE
Goldenberg, DM
Rybak, SM
Citation: Dl. Newton et al., Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents, CR R ONC H, 39(1-2), 2001, pp. 79-86
Authors:
Newton, DL
Kaur, G
Rhim, JS
Sausville, EA
Rybak, SM
Citation: Dl. Newton et al., RNA damage and inhibition of neoplastic endothelial cell growth: Effects of human and amphibian ribonucleases, RADIAT RES, 155(1), 2001, pp. 171-174
Authors:
Newton, DL
Hansen, HJ
Mikulski, SM
Goldenberg, DM
Rybak, SM
Citation: Dl. Newton et al., Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma, BLOOD, 97(2), 2001, pp. 528-535
Authors:
Chen, SL
Le, SY
Newton, DL
Maizel, JV
Rybak, SM
Citation: Sl. Chen et al., A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3 ' UTR of unusual length and structure, NUCL ACID R, 28(12), 2000, pp. 2375-2382
Authors:
Lener, M
Horn, IR
Cardinale, A
Messina, S
Nielsen, UB
Rybak, SM
Hoogenboom, HR
Cattaneo, A
Biocca, S
Citation: M. Lener et al., Diverting a protein from its cellular location by intracellular antibodies- The case of p21Ras, EUR J BIOCH, 267(4), 2000, pp. 1196-1205
Authors:
Iordanov, MS
Ryabinina, OP
Wong, J
Dinh, TH
Newton, DL
Rybak, SM
Magun, BE
Citation: Ms. Iordanov et al., Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis, CANCER RES, 60(7), 2000, pp. 1983-1994
Authors:
Newton, DL
Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Preparation and preclinical characterization of RNase-based immunofusion proteins, METH MOL B, 160, 2000, pp. 387-406
Authors:
Newton, DL
Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Construction of ribonuclease-antibody conjugates for selective cytotoxicity, METH MOL M, 25, 2000, pp. 27-35
Authors:
Newton, DL
Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Preparation of recombinant RNase single-chain antibody fusion proteins, METH MOL M, 25, 2000, pp. 77-95
Authors:
Rybak, SM
Citation: Sm. Rybak, Uncloaking RNases, NAT BIOTECH, 17(5), 1999, pp. 408-408
Authors:
Newton, DL
Pollock, D
DiTullio, P
Echelard, Y
Harvey, M
Wilburn, B
Williams, J
Hoogenboom, HR
Raus, JCM
Meade, HM
Rybak, SM
Citation: Dl. Newton et al., Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice, J IMMUNOL M, 231(1-2), 1999, pp. 159-167
Authors:
Rybak, SM
Newton, DL
Citation: Sm. Rybak et Dl. Newton, Natural and engineered cytotoxic ribonucleases: Therapeutic potential, EXP CELL RE, 253(2), 1999, pp. 325-335
Authors:
Smith, MR
Newton, DL
Mikulski, SM
Rybak, SM
Citation: Mr. Smith et al., Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases, EXP CELL RE, 247(1), 1999, pp. 220-232
Authors:
Newton, DL
Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth, J NAT CANC, 90(23), 1998, pp. 1787-1791
Risultati:
1-14
|